Skip to main content

Nonprofit · EIN 20-0291856

AMYLOIDOSIS FOUNDATION

Tax-exempt · CLARKSTON, MI 48346

Financials

$779K$709K2021$535K$569K2023$689K$603K2024
Revenue Expenses · by fiscal year end
Financials of AMYLOIDOSIS FOUNDATION by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$688,539$602,526$86,013$1,128,603$7,243$1,121,360
December 31, 2023990$535,162$568,920-$33,758$1,050,511$4,622$1,045,889
December 31, 2021990$779,248$709,491$69,757$1,060,679$8,357$1,052,322
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$583,395
Program service revenue
$0
Investment income
$88,510
Net gain from sales of assets
$50,794
Net income from fundraising events
$16,634
Other revenue
$16,634

Expenses

Grants and similar amounts paid
$166,725
Compensation of officers, directors and key employees
$63,050
Other salaries and wages
$110,357
Salaries, compensation and benefits (total)
$186,548
Professional fundraising fees
$0
Occupancy
$10,450
Travel
$27,225
Depreciation
$2,135
Program services (functional)
$482,169
Management and general (functional)
$62,428
Fundraising (functional)
$57,929

Balance sheet and other

Total assets, start of year
$1,050,511
Total assets, end of year
$1,128,603
Total liabilities, end of year
$7,243
Net assets, end of year
$1,121,360
Land, buildings and equipment
$4,481
Publicly traded securities
$905,869
Net assets without donor restrictions
$1,121,360
Gross receipts
$1,017,145
Employees
3
Volunteers
9
Year formed
2003
State of legal domicile
MI

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensation
MARY E ODONNELLPRESIDENT/CEO
Trustee or director, Officer
30$63,050
DANTE BURCHITREASURER
Trustee or director, Officer
5$0
MARK SUTHERLANDCHIEF FINANCIAL OFFICER
Trustee or director, Officer
5$0
ERSKINE WHITE EDDDIRECTOR
Trustee or director
5$0
ADRIENNE MOLTENIDIRECTOR
Trustee or director
5$0
DAN LENIHANDIRECTOR
Trustee or director
5$0
LORI LAWTERDIRECTOR
Trustee or director, Officer
5$0
STACY GOODMANDIRECTOR
Trustee or director
5$0
990 for the year ended December 31, 2023: 8 people
NameTitleHours / weekCompensation
MARY E ODONNELLPRESIDENT/CEO
Trustee or director, Officer
30$62,030
DANTE BURCHITREASURER
Trustee or director, Officer
5$0
MARK SUTHERLANDCHIEF FINANCIAL OFFICER
Trustee or director, Officer
5$0
CHARLOTTE HAFFNERDIRECTOR
Trustee or director
5$0
ADRIENNE MOLTENIDIRECTOR
Trustee or director
5$0
DAN LENIHANDIRECTOR
Trustee or director
5$0
LORI LAWTERDIRECTOR
Trustee or director, Officer
5$0
STACY GOODMANDIRECTOR
Trustee or director
5$0
990 for the year ended December 31, 2021: 7 people
NameTitleHours / weekCompensation
MARY E ODONNELLPRESIDENT/CEO
Trustee or director, Officer
30$56,160
DANTE BURCHITREASURER
Trustee or director, Officer
5$0
MARK SUTHERLANDCHIEF FINANCIAL OFFICER
Trustee or director, Officer
5$0
CHARLOTTE HAFFNERDIRECTOR
Trustee or director
5$0
ADRIENNE MOLTENIDIRECTOR
Trustee or director
5$0
DAN LENIHANDIRECTOR
Trustee or director
5$0
LORI LAWTERDIRECTOR
Trustee or director, Officer
5$0

Address and contacts

Address (IRS master file)
7151 N MAIN ST STE 2, CLARKSTON, MI 48346-1584
In care of
% MARY E ODONNELL
Principal officer (990 for 2024)
MARY ODONNELL, 7151 NORTH MAIN STREET SUITE 2, CLARKSTON, MI 48346
Signed the 990
MARY ODONNELL, PRESIDENT
Phone
(248) 922-9610
Return prepared by
BRIAN R WEILAND & ASSOCIATES PC

Mission

THE ORGANIZATIONS MISSION IS TO INCREASE EDUCATION AND AWARENESS OF AMYLOIDOSIS, TO ASSIST PATIENTS IN FINDING QUALIFIED MEDICAL CARE AND TO SUPPORT RESEARCH.

990 for the year ended December 31, 2024

Program accomplishments

  • RESEARCH AND TRAVEL GRANTS.
    Expenses $166,725 · grants $166,725
  • EXHIBIT AT MEDICAL CONFERENCES AND RAISE AWARENESS OF AMYLOIDOSIS THROUGHOUT THE WORLD.
    Expenses $194,776
  • PATIENT SUPPORT SERVICES AND PUBLIC EDUCATION.
    Expenses $120,668

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
20-0291856
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (170(b)(1)(A)(vi))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
2005
Accounting year ends
December
Files
Form 990 or 990-EZ
Category (NTEE)
Medical research (H25)
Assets (IRS master file)
$1,128,603
Income (IRS master file)
$1,017,145

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$688,539$602,526$1,128,603IRS
990December 2023$535,162$568,920$1,050,511XML
990December 2022$710,435$598,170$1,056,187IRS
990December 2021$779,248$709,491$1,060,679XML
990December 2020–––IRS

990-N: the IRS publishes only the latest e-Postcard per organization; earlier years appear here as 990.tax collects the monthly files. 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS.

Questions about AMYLOIDOSIS FOUNDATION

What is the EIN of AMYLOIDOSIS FOUNDATION?
The employer identification number (EIN) of AMYLOIDOSIS FOUNDATION is 20-0291856.
Is AMYLOIDOSIS FOUNDATION tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2005.
Are donations to AMYLOIDOSIS FOUNDATION tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does AMYLOIDOSIS FOUNDATION file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of AMYLOIDOSIS FOUNDATION due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did AMYLOIDOSIS FOUNDATION last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of AMYLOIDOSIS FOUNDATION?
The 990 for the year ended December 31, 2024 names MARY ODONNELL.
Who are the officers and directors of AMYLOIDOSIS FOUNDATION?
The 990 for the year ended December 31, 2024 lists 8 people; 1 received compensation from the organization, the highest $63,050 (MARY E ODONNELL, PRESIDENT/CEO).
How much revenue does AMYLOIDOSIS FOUNDATION have?
On its 990 for the year ended December 31, 2024 it reported revenue of $688,539, expenses of $602,526 and total assets of $1,128,603 at year end.

Other nonprofits in CLARKSTON

All nonprofits in CLARKSTON · Michigan · Medical research